NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 19 October 2011 From a date to be announced in October 2011, DVLA rules are changing to allow people with insulin-treated diabetes to apply for a group 2 vehicle […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 20 September 2011 A Cochrane review of 20 randomised controlled trials (RCTs) found that intensive blood glucose control did not significantly reduce all-cause mortality or cardiovascular (CV) mortality, compared […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 12 August 2011 The ADDITION-Europe study looked at the effect of early intensive multifactorial management (of HbA1c, blood pressure, cholesterol; and prescription of aspirin) on 5-year cardiovascular outcomes in […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 16 June 2011 This meta-analysis of 13 RCTs (n=17,627) found the use of glitazones was associated with an increased risk of pneumonia or lower respiratory tract infection (LRTI) in […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 22nd February 2011 A study has found that a structured self-monitoring of blood glucose intervention package improved glycaemic control compared with enhanced usual care in patients with poorly controlled type […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 16 December 2010 Rosiglitazone was withdrawn from clinical use across Europe because of concerns over excess cardiovascular (CV) risk. This cohort study found that pioglitazone▼ was associated with the […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 11 November 2010 NICE has issued guidance on the use of liraglutide▼ for the treatment of type 2 diabetes. Liraglutide 1.2mg is a dual therapy option only in very limited […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 21 October 2010 An analysis of the ACCORD study has found that intensive blood glucose control did not reduce composite advanced microvascular outcomes (renal complications, eye complications or peripheral […]

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. 24 September 2010 Suspension of marketing authorisations for rosiglitazone (Avandia® and the combination product with metformin, Avandamet®) has been recommended by the European Medicines Agency (EMA), following concerns over excess […]